| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/23/2006 | WO2006018185A2 Dihydropteridinones for the treatment of cancer diseases |
| 02/23/2006 | WO2006018184A2 Spirocyclic cyclohexane derivatives |
| 02/23/2006 | WO2006018182A1 Combinations for the treatment of diseases involving cell proliferation |
| 02/23/2006 | WO2006018117A1 Substituted 8-aminoalkoxi-xanthines, method for the production thereof and use thereof as medicaments |
| 02/23/2006 | WO2006018116A1 N-(phenyl-oxazol-4-ylmethoxymethyl)-cyclohexyl-succinic acid amide derivatives and related compounds which are used as ppar-ligands (peroxisome proliferator-activated receptors) for the treatment of hyperlipidaemie and diabetes |
| 02/23/2006 | WO2006018088A1 Use of a pde 5 inhibitor for treating and preventing hypopigmentary disorders |
| 02/23/2006 | WO2006018024A2 Cosmetic and pharmaceutical compositions comprising ace inhibitors and/or angiotensin ii receptor antagonists |
| 02/23/2006 | WO2006017994A1 An analgesic pharmaceutical composition |
| 02/23/2006 | WO2006017921A1 Selective muscle relaxant and pharmaceutical compositions |
| 02/23/2006 | WO2006004507A3 New benzothiazole derivatives useful for treating cns disorders |
| 02/23/2006 | WO2005123688A3 3-aminoindazoles |
| 02/23/2006 | WO2005123094A3 Treatment or prevention of skin conditions or tissue conditions in animals using boryloxypyridylmethanones |
| 02/23/2006 | WO2005123075A3 Controlling angiogenesis with anabaseine analogs |
| 02/23/2006 | WO2005120504A3 Cancer treatment method |
| 02/23/2006 | WO2005118557A3 Heterocyclic compounds and their use as aldosterone synthase inhibitors |
| 02/23/2006 | WO2005110980A3 Aryl sulfones and uses related thereto |
| 02/23/2006 | WO2005105062A3 2-methylthiazolidine-2,4-dicarboxylic acid-containing combination preparations |
| 02/23/2006 | WO2005105039A8 Solid pharmaceutical form comprising an ltb4 antagonist |
| 02/23/2006 | WO2005102319A3 Use of melatonin in preventing postoperative complications |
| 02/23/2006 | WO2005093422A3 Carbohydrate-encapsulated quantum dots for biological imaging |
| 02/23/2006 | WO2005092362A3 Pharmaceutical combined preparation containing a therapeutic protein |
| 02/23/2006 | WO2005089118A3 Novel bicyclic compounds as modulators of androgen receptor function and method |
| 02/23/2006 | WO2005086808A3 NOVEL DICATIONIC IMIDAZO[1,2-a]PYRIDINES AND 5,6,7,8-TETRAHYDRO-IMIDAZO[1,2a]PYRIDINES AS ANTIPROTOZOAL AGENTS |
| 02/23/2006 | WO2005079519A3 Substituted bicycloalkylamine derivatives as modulators of chemokine receptor activity |
| 02/23/2006 | WO2005079497A3 Substituted fused bicyclic amines as modulators of chemokine receptor activity |
| 02/23/2006 | WO2005079272A3 Compositions of non-steroidal anti-inflammatory drugs and decongestants or anti-histamines |
| 02/23/2006 | WO2005077424A3 Conjugate for destroying cancer cells |
| 02/23/2006 | WO2005069771A3 Small molecule antagonists of bcl-2 family proteins |
| 02/23/2006 | WO2005067930A3 Serotonin receptor antagonists for the treatment of neurological disease |
| 02/23/2006 | WO2005065429A3 Composition and method for treatment of hepatic encephalopathy |
| 02/23/2006 | WO2005056002A3 Use of inductors of the degradation pathway of gamma-butyrolactone for inactivating the homoserine lactone n-acyl signal of gram-negative pathogenic bacteria |
| 02/23/2006 | WO2005053614A3 Advanced indolinone based protein kinase inhibitors |
| 02/23/2006 | WO2005048953A3 Amide derivatives as kinase modulators |
| 02/23/2006 | WO2005028631A3 A novel biodegradable elastomeric scaffold for tissue engineering and light scattering fingerprinting methods for testing the same |
| 02/23/2006 | WO2005026164A8 Pharmacologically active imidazo[4,5-c]pyridines |
| 02/23/2006 | WO2005004988A3 Compositions and methods relating to novel compounds and targets thereof |
| 02/23/2006 | WO2004093814A3 Compositions of a cyclooxygenase-2 selective inhibitor and a sodium channel blocker |
| 02/23/2006 | WO2004080430A3 Methods of improving skin quality |
| 02/23/2006 | WO2004071458A3 REGULATION OF FOOD INTAKE AND GLUCOSE PRODUCTION BY MODULATION OF LONG-CHAIN FATTY ACYL-CoA LEVELS IN THE HYPOTHALAMUS |
| 02/23/2006 | WO2004043406A3 ENGINEERED RNAi ADENOVIRUS SILENCING EXPRESSION (ERASE) OF DNA REPAIR PROTEINS |
| 02/23/2006 | WO2003072732A3 Methods of making hypermutable cells using pmsr homologs |
| 02/23/2006 | WO2003047523A3 Raf-mek-erk pathway inhibitors to treat cancer |
| 02/23/2006 | US20060041164 liver X receptor LXR agonists; increasing ABCA1, ABCG1, and apolipoprotein E expression, increasing cholesterol efflux from peripheral cells, cardiovascular disease, inflammation; 2-(3-{3-[[2-Chloro-3-(trifluoromethyl)benzyl](2,2-diphenylethyl)amino]-2-methyl-propoxy}-phenyl)acetic acid methyl ester |
| 02/23/2006 | US20060041146 Substituted hydantoins |
| 02/23/2006 | US20060041140 5,6-dimethoxy-2-(4-pyridyl)methyl-1-indanone is hydrogenated using platinum oxide catalyst in the presence of hydrochloric acid under a pressure of 2 bars to give 4-[(5,6-dimethoxy-1-indanon)-2-yl]methylpiperidine hydrochloride |
| 02/23/2006 | US20060041139 Antagonists for melanin concentrating hormone-1 receptors; antidepressants, anxiolytic agents; incontinence, obesity |
| 02/23/2006 | US20060041137 Kinase inhibitors |
| 02/23/2006 | US20060041134 Silyl ethers |
| 02/23/2006 | US20060041132 Novel triazolo pyrimidine compounds |
| 02/23/2006 | US20060041131 useful in the treatment and prevention of proliferative diseases, for example, cancer, inflammation and arthritis |
| 02/23/2006 | US20060041130 Syntheses of quinazolinones |
| 02/23/2006 | US20060041129 Enantiomers of selected fused heterocyclics and uses thereof |
| 02/23/2006 | US20060041128 Selected fused heterocyclics and uses thereof |
| 02/23/2006 | US20060041127 Method for the regioselective preparation of substituted benzo[g]quinoline-3-carbonitriles and benzo[g]quinazolines |
| 02/23/2006 | US20060041125 Substituted pyrido-pyridazine derivatives which enhance cognition via the gaba-a receptors |
| 02/23/2006 | US20060041124 Process for preparing pyrrolotriazine kinase inhibitors |
| 02/23/2006 | US20060041123 Antibacterial agents |
| 02/23/2006 | US20060041025 5-Alkyl (4-26 carbon atoms)-2-phenoxyphenols; enoyl reductase enzyme inhibitor; drug resistance; side-effect reduction; nicrobiocides; carriers |
| 02/23/2006 | US20060041024 Polycationic compounds and uses thereof |
| 02/23/2006 | US20060041023 Facially amphilic polymers and oligomers and uses thereof |
| 02/23/2006 | US20060041022 Treatment of amyotrophic lateral sclerosis with nimesulide |
| 02/23/2006 | US20060041021 Treatment of female sexual dysfunction with vasoactive intestinal polypeptide agonists |
| 02/23/2006 | US20060041020 Alzheimer's disease, modulate the processing of amyloid precursor protein by gamma-secretase |
| 02/23/2006 | US20060041019 Inhibitor of anticancer drug side effect |
| 02/23/2006 | US20060041017 Synergistic conjugated linoleic acid (CLA) and carnitine combination |
| 02/23/2006 | US20060041016 Composition and method for the treatment of psoriasis |
| 02/23/2006 | US20060041015 Administering treosulfan, busulfan, dimethyl busulfan, pentasulfan or hepsulfam, optionally immunomodulatory interferon- and/or glatriamer acetate; for treatment of relapsing-remitting, primary progressive and in particular secondary progressive MS |
| 02/23/2006 | US20060041014 Treatment of male sexual dysfunction |
| 02/23/2006 | US20060041013 Alanosine formulations and methods of use |
| 02/23/2006 | US20060041012 Prepared by reacting aqueous solutions of trans-L1,2-cyclohexanediamine and Li, Na or K tetrahaloplatinate; converting the cis-dihalo-(trans-L-1,2-cyclohexanediamine) Pt (II) formed to oxaliplatin, particularly by reacing with silver oxalate |
| 02/23/2006 | US20060041011 For therapy and prophylaxis of diseases or disorders such as migraine headache pain and post-chemotherapy or post-operative surgery nausea and vomiting |
| 02/23/2006 | US20060041010 (-)-Epigallocatechin gallate derivatives for inhibiting proteasome |
| 02/23/2006 | US20060041009 Pharmaceutical compound containing silymarin and carbopol, production method thereof and use of same as a regenerator of tissue and pancreatic cells with endogenous secretion damaged by diabetes mellitus |
| 02/23/2006 | US20060041008 Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders |
| 02/23/2006 | US20060041007 Metastable benzoxepne derivatives which can be used in the treatment of dyslipidaemia a therosclerosis and diabetes, pharmaceutical compositions comprising them and processes for the preparation thereof |
| 02/23/2006 | US20060041006 PDE4B inhibitors and uses therefor |
| 02/23/2006 | US20060041005 Process for the synthesis C-2, C-3 substituted N-alkylated indoles useful as CPLA2 inhibitors |
| 02/23/2006 | US20060041004 Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-methylene-4H-carbazol-4-one and ondansetron therefrom |
| 02/23/2006 | US20060041003 based on partially unsaturated fused rings phenanthracene, benzo[a]azulene, e.g. 3-bromo-8a-butyl-6-hydroxy-8,8a-dihydrocyclopenta[a]inden-2(1H)-one; variety of conditions such as hot flashes, anxiety, depression, estrogen-dependent cancers, inflammatory diseases, bone disorders, incontinence |
| 02/23/2006 | US20060041002 Guanylhydrazone compounds, compositions, methods of making and using |
| 02/23/2006 | US20060041001 Useful in the treatment of diseases or conditions susceptible to adrenergic regulation controlled by alpha-2 adrenergic receptors |
| 02/23/2006 | US20060041000 Hydantoin derivatives; for treatment of asthma, chronic obstructive pulmonary diseases (COPD), arthritis, cancer, heart disease and nephritis |
| 02/23/2006 | US20060040999 CETP inhibitors |
| 02/23/2006 | US20060040998 Thiazolidinone amides, thiazolidine carboxylic acid amides, methods of making, and uses thereof |
| 02/23/2006 | US20060040997 Benzthiazole-3 oxides useful for the treatment of proliferative disorders |
| 02/23/2006 | US20060040996 Administering compound such as 5 {[2-(dimethylamino)ethyl]amino}-2-methyl-1,3-benzothiazole-4,7-dione |
| 02/23/2006 | US20060040995 Method for preparing hydroxypicolinic scid derivatives |
| 02/23/2006 | US20060040994 Substituted amide beta secretase inhibitors |
| 02/23/2006 | US20060040993 Having (i) an infra red spectrum containing peaks at 1549, 759, 600 cm-1; (ii) a Raman spectrum containing peaks at 1338, 1183, 990, 552 cm-1; and/or (iii) an X-ray powder diffraction pattern containing peaks at 6.2, 11.9, 15.9, 19.8, 22.7 degrees 2 theta . |
| 02/23/2006 | US20060040992 Antiinflammatory 3-arylthio-3-thiazolyl-alkylamines |
| 02/23/2006 | US20060040991 Pharmaceutical presentation form for oral administration of a poorly soluble active compound, process for its preparation and kit |
| 02/23/2006 | US20060040990 Epothilone derivatives, process for their production, and their pharmaceutical use |
| 02/23/2006 | US20060040989 N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein b secretion |
| 02/23/2006 | US20060040988 antiinflammatory, antipyretic and analgesic agents; side effects redution; N-(cyclohexylmethyl)-6-[4-(methylsulfonyl)phenyl]-4-(trifluoromethyl)-2-pyridinamine; osteoarthritis; rheumatoid arthritis |
| 02/23/2006 | US20060040987 "soft" analog of fentanyl; derivative of 1,4-disubstituted piperdine compounds; opioid receptor agonist; analgesic; high degree of efficiency against extreme pain; less side effects then fentanyl; oral bioavailability |
| 02/23/2006 | US20060040986 Erythropoietin production accelerator |
| 02/23/2006 | US20060040985 Therapeutic agent for treating respiratory diseases containing 4-hydroxypiperidine derivative as active ingredient |
| 02/23/2006 | US20060040984 Novel piperidine derivatives for use in the treatment of chemokine medicated disease states |
| 02/23/2006 | US20060040983 Quinolinyl-pyrrolopyrazoles |
| 02/23/2006 | US20060040982 2-(5-aminocarbonyl-1H-imidazol-4-ylamino)-8-chloroquinoline; inhibit the IgE receptor signaling cascade; inhibit degranulation of mast and/or basophil cells; allergies; scleroderma, increased fibrosis, keloids, post-surgical scars, pulmonary fibrosis, vascular spasms, migraine, reperfusion injury |